Scientific Sessions

 


On This Page:


The schedule below reflects the invited program only. The complete schedule, including the submitted program, will be available closer to the conference.

Plenary Sessions

10:30 - 11:15 a.m.

Association Welcome


Session: PL-01-01

11:15 - 11:45 a.m.

Understanding the Earliest Phases of Alzheimer’s Disease

Marilyn Albert
Johns Hopkins University School of Medicine, USA
Theme: Therapeutics
Session: PL-01-02

10:30 - 11 a.m.

Sleep, Brain and Cognition


Ruth M. Benca
University of California, Irvine, USA
Theme: Therapeutics
Session: PL-02-01

11 - 11:30 a.m.

Alzheimer’s Disease Blood-Based Biomarkers and AD Control


SangYun Kim
Seoul National University, South Korea
Theme: Diagnosis and Prognosis
Session: PL-02-02

10:30 - 11 a.m.

Inge Grundke-Iqbal Award for Alzheimer’s Research: Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia


Shane A. Liddelow, Ph.D.
NYU School of Medicine, USA
Theme: Basic and Translational Science
Session: PL-03-01

11 - 11:30 a.m.

The Epidemiology of Diversity and Dementia


Rachel Whitmer
University of California, Davis, USA
Theme: Public Health and Psychosocial
Session: PL-03-02

10:30 - 11 a.m.

Imaging Neurodegeneration With MRI: What Is New?


David Wolk
University of Pennsylvania Memory Center, USA
Theme: Diagnosis and Prognosis
Session: PL-04-01

11 - 11:30 a.m.

The Cellular Phase of Alzheimer’s Disease


Bart De Strooper
University College London, United Kingdom; University of Leuven, Belgium
Theme: Basic and Translational Science
Session: PL-04-02

10:30 - 11 a.m.

Microglia in Neurodegenerative Conditions


Marco Colonna
Washington University in St. Louis, USA
Theme: Basic and Translational Science
Session: PL-05-01

11 - 11:30 a.m.

Precision Medicine, Population Neuroscience and Comprehensive Care: Partners to Develop and Deliver Effective Prevention and Treatments for Dementia


Sudha Seshadri
The University of Texas Health Science Center at San Antonio, USA
Theme: Public Health & Psychosocial
Session: PL-05-02


Symposium Sessions

Sunday, July 14
  • Disparities in Access to Dementia Care and Prevention [S1-01]
    8 - 9:30 a.m.

    Theme: Public Health and Psychosocial

PRESENTATIONS

SPEAKERS


Dementia Prevention Programs in Urban and Regional Aboriginal Communities in Australia [S1-01-01]

Kylie Radford
University of New South Wales, Australia


Effects of Health Literacy on Access to Dementia Care [S1-01-02]

Jennifer Lingler
University of Pittsburgh, USA


Improving the Lives of People with Dementia - The OECD Perspective [S1-01-03]

Elina Suzuki
Organization for Economic Co-operation and Development, France


Dementia As Access Barrier in Palliative Care [S1-01-04]

Li Gang
University of Pittsburgh, USA


Sunday, July 14
  • “Rare Variants” And Their Role In Genetic Etiology And Disease [S1-02]
    8 - 9:30 a.m.

    Theme: Basic and Translational Science

PRESENTATIONS

SPEAKERS


Clustering of Rare Variants in Alzheimer Disease and Related Disorders in the Colombian Population: A Genomic Study [S1-02-01]

Ken Kosik
University of California, USA


The Potential Contribution of Rare Variants to Neurodegenerative Brain Dementia [S1-02-02]

Gary Beecham
The Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, USA


Whole-Exome Sequencing in 20,197 Persons for Rare Variants in Alzheimer's Disease [S1-02-03]

Richard Mayeux
Columbia University Medical Center, USA


High-Throughput Identification of Noncoding Functional SNPs [S1-02-04]

Gang Li
University of Pittsburgh School of Medicine, USA


Monday, July 15
  • PET and CSF Markers of Neuroinflammation [S2-01]
    8 - 9:30 a.m.

    Theme: Diagnosis and Prognosis

PRESENTATIONS

SPEAKERS


PET Markers of Microglia [S2-01-01]

Robert Innis
National Institute of Mental Health, USA


PET Markers of Astrocytes [S2-01-02]

Elena Rodriguez-Vieitez
Karolinska Institute, Sweden


Neuroinflammation: CSF Perspective [S2-01-03]

Shorena Janelidze
Lund University, Sweden


Fluid Biomarkers of Neuroinflammation [S2-01-04]

Charlotte Teunissen
VU University Medical Center, Netherlands


Monday, July 15
  • Precision Medicine [S2-02]
    8 - 9:30 a.m.

    Theme: Therapeutics

PRESENTATIONS

SPEAKERS


Precision Medicine Model for Targeted NSAID Therapy in AD [S2-02-01]

Sid O'Bryant
University of North Texas Health Science Center, USA


PPAR-Gamma [S2-02-02]

Michael Heneka
German Center for Neurodegenerative Diseases (DZNE), Germany


Insulin-Resistant Sub-Typing [S2-02-03]

Suzanne Craft
Wake Forest School of Medicine, USA


Subtyping of Clinical Subjects through Exosome Analyses [S2-02-04]

Dimitrios Kapogiannis
National Institute on Aging/National Institutes of Health (NIA/NIH), USA


Tuesday, July 16
  • Overlapping AD Pathologies and their Influence on Disease Phenotypes [S3-01]
    8 - 9:30 a.m.

    Theme: Diagnosis and Prognosis

PRESENTATIONS

SPEAKERS


Alzheimer’s and Vascular Disease: Pathologic Perspective [S3-01-01]

Costantino Iadecola
Weill Cornell Medicine, USA


Alzheimer’s Disease and Subcortical Vascular Cognitive Impairment (SVCI): Biomarker Perspective [S3-01-02]

Duk Na
Samsung Medical Center; Sungkyunkwan University School of Medicine, Korea, Republic of Korea (South)


Alzheimer’s and Lewy Body Disease: Pathologic Perspective [S3-01-03]

David Irwin
University of Pennsylvania, USA


Alzheimer’s and Lewy Body Disease: Biomarker Perspective [S3-01-04]

Evelien Lemstra
Amsterdam University Medical Centers, Netherlands


Tuesday, July 16
  • Responder Analyses Leading to Hypothesis Generation for Prospective Study Designs [S3-02]
    8 - 9:30 a.m.

    Theme: Therapeutics

PRESENTATIONS

SPEAKERS


Statistics [S3-02-01]

Suzanne Hendrix
Pentara Corporation, USA


Multi-Crossover Randomized Control Design Approaches Based on Analyses of Responder/Non-Responder Outcomes [S3-02-02]

Steven Arnold Massachusetts General Hospital, USA; Harvard Medical School, USA
To be announced.


Statistical Considerations for Efficient Designs within a Platform Trial Approach [S3-02-03]

Karen Messer
University of California San Diego, USA


To be announced. [S3-02-04]

Eric Siemers
Cogstate, Ltd., USA


Wednesday, July 17
  • National Dementia Registries: Quality Control and Recruitment of Research Participants [S4-01]
    8 - 9:30 a.m.

    Theme: Public Health and Psychosocial

PRESENTATIONS

SPEAKERS


The Brain Health Registry for Recruitment of Research Participants: 5 Year Experience [S4-01-01]

Michael Weiner
University of California, San Francisco, USA


The Dutch Brain Health Registry for Recruitment of Research Participants [S4-01-02]

Marissa Zwan
VU University Medical Center, Netherlands


Swedish Clinical Quality Registry for Dementia [S4-01-03]

Dorota Religa
Karolinska Institute, Sweden


Australian Clinical Quality Registry for Dementia [S4-01-04]

Stephanie Ward
Monash University, Australia


Thursday, July 18
  • Delirium in Dementia: A Translational Aspect [S5-01]
    8:30 - 10 a.m.

    Theme: Basic and Translational Science

PRESENTATIONS

SPEAKERS


Description and Impact of Delirium on Dementia [S5-01-01]

Daniel Davis
University College London, United Kingdom


Biomarkers in Delirium [S5-01-02]

Gideon Caplan
University of New South Wales, Australia


Neurobiology of Delirium and Its Intersection with Dementia: Insights from Animal Models [S5-01-03]

Colm Cunningham
Trinity College Dublin, Ireland


Systemic Inflammation Signaling to the Brain [S5-01-04]

Roosmarijn Vandenbroucke
Ghent University, Belgium


Become an ISTAART Member

Members of this professional society stay connected to the field through exclusive member benefits and programs. Join for just $30* at the Alzheimer's Association (Booth 500).

*Offer available onsite at AAIC (through 7/18/19). Applies only to registrants who paid the non-member fee.

join today

Preconferences & Educational Workshops

Learn the basics or brush up on your skills by attending an AAIC preconference or educational workshop. These events provide the opportunity to explore the newest findings and practices for the prevention and treatment of Alzheimer's disease and other dementias.

Learn More

Join the Conversation #AAIC19

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs